Literature DB >> 6857455

Improved survival rate for intraperitoneal autotransplantation of the spleen following pneumococcal pneumonia.

C D Livingston, B A Levine, K R Sirinek.   

Abstract

One hundred and ten Sprague-Dawley rats were randomly assigned to one of four treatment groups: 1, sham control; 2, splenectomy; 3, splenectomy and implantation of diced splenic tissue among the leaves of the small intestinal mesentery, and 4, splenectomy and intraportal injection of emulsified splenic tissue. Twelve weeks postoperatively, all of the rats were challenged with Type III Streptococcus pneumoniae by transtracheal injection. Rats with intraportal splenic autotransplants had an early mortality significantly higher than that of asplenic rats. Rats with small intestinal mesentery implants had a mortality not significantly different from that of sham control rats but significantly lower than that of rats that underwent splenectomy. Thus, intraperitoneal splenic autotransplantation provides a protective effect against postsplenectomy pulmonary sepsis and serves as a method for preservation of splenic function.

Entities:  

Mesh:

Year:  1983        PMID: 6857455

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  4 in total

1.  Heterotopic autologous splenic grafts in rat. Morphological studies.

Authors:  M T Moore; A S Leong; P A Drew; G K Kiroff; G G Jamieson
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

2.  Methods of splenic preservation and their effect on clearance of pneumococcal bacteremia.

Authors:  K S Scher; C Scott-Conner; C W Jones; A F Wroczynski
Journal:  Ann Surg       Date:  1985-11       Impact factor: 12.969

3.  [Pneumococcus-induced septicemia in normal and splenectomized rabbits].

Authors:  J Melissas; A Wasas; A A Wadee; E Korkozoglou; P Flessas
Journal:  Langenbecks Arch Chir       Date:  1992

4.  Autologous splenic transplantation for splenic trauma.

Authors:  P W Pisters; H L Pachter
Journal:  Ann Surg       Date:  1994-03       Impact factor: 12.969

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.